Article Information
- August 24, 2022.
Article Versions
- Version 1 (December 11, 2021 - 19:49).
- You are currently viewing Version 2 of this article (August 24, 2022 - 16:12).
- View Version 3, the most recent version of this article.
REVISION SUMMARY
We've extended the results of the previous paper to include the emergence of Omicron in the United States. We've also adjusted the free Rt model to be parameterized in terms of the growth advantages as an extension of our fixed growth model. We've added an analysis of the posterior wave sizes and growth advantages as estimated by our models. Additionally, we've corrected a couple of incorrect citation placements and typos.
Author Information
- 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- 2Department of Applied Mathematics, University of Washington, Seattle, WA, USA
- 3Howard Hughes Medical Institute, Seattle, WA, USA
- ↵*Corresponding author: mfiggins{at}uw.edu